Itromed SB 130mg Capsule contains Itraconazole 130mg, a broad-spectrum triazole antifungal agent effective against a variety of fungal infections. Itromed SB works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is indicated for the treatment of systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and dermatophytosis. It is also used in the management of oropharyngeal and esophageal candidiasis, as well as other infections caused by susceptible fungal pathogens. Itromed SB 130mg Capsule should be administered orally with food to enhance absorption. Dosage and duration depend on the type and severity of the infection, and therapy should be guided by clinical response and laboratory findings. Caution is advised in patients with hepatic impairment or congestive heart failure due to potential adverse effects. Common side effects include gastrointestinal disturbances, headache, and rash. Drug interactions are significant, as Itraconazole is a potent inhibitor of cytochrome P450 3A4 enzymes; thus, concomitant use with certain medications requires careful monitoring. Itromed SB 130mg Capsule should be used under medical supervision to ensure efficacy and safety.